DNA

#3004
Ginkgo Bioworks Holdings, Inc.
7.6300 USD
+14.91%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
7.5329
7.6900
년간 변동
5.3700
9.7200
일일 변동
+14.91%
월간 변동
+9.00%
6달 변화
-14.08%
년간 변동율
-14.08%
이전 종가
6.6400
Open
7.5329
Bid
Ask
Low
7.5329
High
7.6900
양
276
Open full chart

Financials

Overview 성명 Statistics
Quarterly Annual
  • Market Capitalization 449.5928 M
  • Employee 485
  • Founded 2008
  • CEO Jason Kelly
  • Website www.ginkgobioworks.com
  • Headquarter Delaware, United States
  • FIGI BBG00YPS1KY3
  • Industry Technology
총매출
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.47
Price to sales ratio
2.71

Ginkgo Bioworks Holdings Inc Class A

Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.

뉴스